Optimal Switching Antiplatelet Regimen in Patients with Ticagrelor to a Thienopyridine in Korean Patients (SWAPT-K Study)
Journal of Cardiovascular Pharmacology and Therapeutics
Published online on April 16, 2026
Abstract
Journal of Cardiovascular Pharmacology and Therapeutics, Volume 31, January-December 2026.
BackgroundDual antiplatelet therapy (DAPT) with aspirin and potent P2Y12inhibitors such as ticagrelor effectively reduces ischemic events but increases bleeding risk. In patients requiring long-term DAPT, switching from ticagrelor to a thienopyridine is ...
BackgroundDual antiplatelet therapy (DAPT) with aspirin and potent P2Y12inhibitors such as ticagrelor effectively reduces ischemic events but increases bleeding risk. In patients requiring long-term DAPT, switching from ticagrelor to a thienopyridine is ...